 SEATTLE and VANCOUVER, British Columbia, April 21, 2022 GLOBE NEWSWIRE -- Achieve Life Sciences, Inc. Nasdaq: ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will report its first quarter financial results and provide an update on the cytisinicline development program on Thursday, May 12, 2022, at 4:30 PM EDT. To access the webcast, please use the following link 1Q22 Earnings Webcast . Alternatively, you may access the live conference call by dialing 877 472-9809 U.S. Canada or 629 228-0791 International and referencing conference ID 3887417. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days. 